Background Peripheral arterial disease is a common complication of diabetes mellitus, and hyperinsulinaemia has been associated with an increased incidence of intermittent claudication in diabetic subjects. Our aim was to investigate the relationship between hyperinsulinaemia and peripheral arterial disease in the non-diabetic general population.
Methods Eighty-three cases with peripheral arterial disease and 88 age- and sex-matched controls were selected from non-diabetic participants in the Edinburgh Artery Study, a survey of 1592 men and women aged 55-74 years randomly selected from the general population.
Results Mean plasma insulin, 1 h after a 75 g oral glucose load, was higher in cases than in controls (73.6 versus 59.8 mU/l; P < 0.05). The relationship between insulin and disease was independent of blood pressure [odds ratio (OR) 2.04; 95% Cl 1.11-3.74; P ≤ 0.05] and partially independent of low- and high-density lipoprotein cholesterol and triglycerides (OR 1.86; 95% Cl 0.99-3.48; P ≤ 0.1). Mean 1 h insulin was higher in current or ex-smokers than in those who had never smoked (P ≤ 0.05) and when smoking was added to the multivariate model, the relationship between insulin and disease diminished (OR 1.64: 95% Cl 0.83-3.23; P > 0.1).
Conclusions In the non-diabetic general population, peripheral arterial disease is associated with post-glucose hyperinsulinaemia, independently of blood pressure, lipoproteins and triglycerides. Some of this association may be mediated by a relationship between hyperinsulinaemia and smoking.
JarrettRJ: Diabetes Mellitus. In Epidemiology of Peripheral Vascular Disease. Edited by FowkesFGR.London: Springer-Verlag, 1991:187–193.
2.
ElliottTGVibertiG: Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: A critical appraisalBalliere's Clinical Endocrinology and Metabolism1993, 7:1079–1103.
3.
FontbonneACharlesMAThibultNRichardJLClaudeJRWarnetJM et al.: Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-upDiabetologia1991, 34:356–361.
4.
PyöräläKSavolainenEKaukolaSHaapakoskiJ: Plasma insulin as coronary heart disease risk factor. Relationship to other risk factors and predictive value during 9.5 year follow up of the Helsinki Policeman Study PopulationActa Med Scand Suppl1985, 701:38–52.
5.
YarnellJWGSweetnamPMMarksVTealeJDBoltonCH: Insulin in ischaemic heart disease: Are associations explained by triglyceride concentrations? The Caerphilly prospective studyBr Heart J1994, 171:293–296.
6.
DesprésJ-PLamarcheBMauriègePCantinBDagenaisGRMoorjaniS: Hyperinsulinaemia as an independent risk factor for ischaemic heart diseaseN Engl J Med1996, 334:952–957.
7.
WelbornTA: Serum-insulin in essential hypertension and in peripheral vascular diseaseLancet1966, 1:1336–1337.
8.
SloanJMMackayJSSheridanB: Glucose and insulin response in atherosclerosisBMJ1970, 4:586–588.
9.
StoutRW: Insulin and atheroma: 20-year perspectiveDiabetes Care1990, 13:631–654.
10.
FacchiniFSHollenbeckCBJeppesenJChenY-DReavenGM: Insulin resistance and cigarette smokingLancet1992, 339:1128–1130.
11.
FowkesFGRHousleyECawoodEHHMacIntyreCCARuckleyCVPrescottRJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general populationInt J Epidemiol1991, 20:384–391.
12.
LengGCLeeAJFowkesFGRWhitemanMDunbarJHousleyE et al.: Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general populationInt J Epidemiol1996, 25:1172–1181.
13.
RoseGA: The diagnosis of ischaemic heart pain and intermittent claudication in field surveysBull WHO1962, 27:645–658.
14.
PrineasRJCrowRSBlackburnH: The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. London: John Wright, 1982.
15.
World Health Organization Expert Committee: Second Report on Diabetes Mellitus, 1980. WHO Tech Rep Ser No 646.
16.
FriedewarldWTLevyRIFredricksonDS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClinical Chemistry1972, 18:499–502.
17.
UusitupaMJJNiskanenLKSiitonenOVoutilainenEPyoralaK: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjectsCirculation1990, 82:27–36.
18.
GodslandIFStevensonJC: Insulin resistance: Syndrome or tendencyLancet1995, 346:100–103.
19.
LaaksoMEdelmanSVBrechtelGBaronAO: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese manJ Clin Invest1990, 85:1844–1852.
20.
BaronAD: Hemodynamic actions of insulinAm J Physiol1994, 267:E187–E202.
21.
LaaksoMSarlundHSalonenRSuhonenMPyöräläKSalonenJT: Asymptomatic atherosclerosis and insulin resistanceArterioscler Thromb1991, 11:1068–1076.
22.
CullenKStenhouseNSWearneKLWelbornTA: Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year studyJ Chronic Dis1983, 36:371–377.
23.
Barrett-ConnorELCohnBAWingardDL: Why is diabetes mellitus a stronger risk factor for fatal ischaemic heart disease in women than in men?JAMA1991, 265:627–631.
24.
ReunanenATakkunenHAromaaA: Prevalence of intermittent claudication and its effects upon mortalityActa Med Scand1982, 211:249–256.
25.
PowellJT: Smoking. In Epidemiology of Peripheral Vascular Diseases. Edited by FowkesFGR.Springer-Verlag, 1991:187–193.
26.
RönnemaaTRönnemaaEMPuukkaPPyöräläKLaaksoM: Smoking is independently associated with high plasma insulin levels in nondiabetic menDiabetes Care1996, 11:1229–1232.
